• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
France Wound Care Management Investment Opportunities, Analysis and Forecasts to 2012 Product Image

France Wound Care Management Investment Opportunities, Analysis and Forecasts to 2012

  • ID: 604362
  • September 2008
  • Region: France
  • 172 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Coloplast A/S
  • Ethicon, Inc.
  • HARTMANN GROUP
  • Smith & Nephew Plc
  • MORE

France Wound Care Management Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to France wound care management market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in France

Scope

- The report provides wound care management information broken down into detailed categories and segments in France.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory READ MORE >

FEATURED COMPANIES

  • Coloplast A/S
  • Ethicon, Inc.
  • HARTMANN GROUP
  • Smith & Nephew Plc
  • MORE

1 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 14
2.1 What Is This Report About? 14
2.2 Definitions 14
2.2.1 Wound Care Management 14
3 Healthcare Sector Review 16
3.1 Healthcare Sector Review 16
3.2 Healthcare Expenditure 16
3.3 Healthcare Infrastructure 17
3.3.1 Healthcare Personnel Data 18
3.3.2 Healthcare Facilities Data 19
3.4 Healthcare Policy 20
4 Wound Care Management in France 21
4.1 Wound Care Management Overall Revenues (2000-2012) 21
4.2 Wound Care Management Overall Volume (2000-2012) 27
4.3 Wound Care Management Overall Company Shares (2005-2006) 30
5 Wound Closure Devices in France 31
5.1 Wound Closure Devices Overall Revenues (2000-2012) 31
5.1.1 Skin Closure Devices Overall Revenues (2000-2012) 35
5.1.2 Hemostats Overall Revenues (2000-2012) 37
5.1.3 Tissue Sealants Overall Revenues (2000-2012) 39
5.2 Wound Closure Devices Overall Volume (2000-2012) 41
5.2.1 Skin Closure Devices Overall Volume (2000-2012) 43
5.2.2 Hemostats Overall Volume (2000-2012) 45
5.2.3 Tissue Sealants Overall Volume (2000-2012) 47
5.3 Wound Closure Devices Average Price (2000-2012) 49
5.3.1 Hemostats Average Price (2000-2012) 49
5.3.2 Tissue Sealants Average Price (2000-2012) 51
5.3.3 Skin Closure Devices Average Price (2000-2012) 53
5.4 Wound Closure Devices Distribution Share (2005-2006) 55
5.5 Wound Closure Devices Company Share (2005-2006) 56
6 Ostomy in France 57
6.1 Ostomy Overall Revenue (2000-2012) 57
6.2 Ostomy Overall Volume (2000-2012) 59
6.3 Ostomy Average Price (2000-2012) 61
6.4 Ostomy Distribution Share (2005-2006) 63
6.5 Ostomy Company Share (2005-2006) 64
7 Advance Wound Management in Germany 65
7.1 Advanced Wound Management Overall Revenue (2000-2012) 65
7.2 Advanced Wound Management Overall Volume (2000-2012) 67
7.3 Advanced Wound Management Average Price (2000-2012) 69
7.4 Advanced Wound Management Distribution Share (2005-2006) 71
7.5 Advanced Wound Management Company Share (2005-2006) 72
8 Traditional Wound Management in France 73
8.1 Traditional Wound Management Overall Revenue (2000-2012) 73
8.2 Traditional Wound Management Overall Volume (2000-2012) 75
8.3 Traditional Wound Management Average Price (2000-2012) 77
8.4 Traditional Wound Management Distribution Share (2005-2006) 79
8.5 Traditional Wound Management Company Share (2005-2006) 80
9 Compression Therapy in France 81
9.1 Compression Therapy Overall Revenue (2000-2012) 81
9.2 Compression Therapy Overall Volume (2000-2012) 83
9.3 Compression Therapy Average Price (2000-2012) 85
9.4 Compression Therapy Distribution Share (2000-2012) 87
9.5 Compression Therapy Company Share (2005-2006) 88
10 HARTMANN GROUP Company Profile 89
10.1 Company Overview 89
10.2 Business Overview 89
10.2.1 Incontinence Management 89
10.2.2 Operating Theater Management 89
10.2.3 Other GROUP Activities 90
10.2.4 Wound Management 90
10.2.5 Products 91
10.2.6 History 92
10.3 Value Chain Analysis 94
10.3.1 Manufacturing 94
10.3.2 Product Development 94
10.3.3 Sales and Marketing 95
10.4 SWOT Analysis 95
10.4.1 HARTMANN GROUP Strengths 95
10.4.2 HARTMANN GROUP Weaknesses 96
10.4.3 HARTMANN GROUP Opportunities 96
10.4.4 HARTMANN GROUP Threats 97
10.5 Financial and Operational Review 99
10.6 Locations And Subsidiaries 100
10.6.1 Other Locations & Subsidiaries 101
11 Coloplast A/S Company Profile 102
11.1 Company Overview 102
11.2 Business Overview 102
11.2.1 Medical Care 102
11.2.2 Major Products and Services 103
11.2.3 History 103
11.3 Value Chain Analysis 105
11.3.1 Manufacturing 105
11.3.2 Product Development 106
11.3.3 Sales and Marketing 107
11.4 SWOT Analysis 108
11.4.1 Coloplast A/S Strengths 108
11.4.2 Coloplast A/S Weaknesses 109
11.4.3 Coloplast A/S Opportunities 109
11.4.4 Coloplast A/S Threats 110
11.5 Financial and Operational Review 111
11.5.1 Financial Statements 111
11.5.2 Financial Ratios 112
11.5.3 Share Holding Structure 113
11.6 Locations And Subsidiaries 114
12 Ethicon, Inc. Company Profile 116
12.1 Company Overview 116
12.2 Business Overview 116
12.2.1 Products 117
12.3 Locations And Subsidiaries 118
12.3.1 Other Locations & Subsidiaries 118
13 Baxter International, Inc. Company Profile 120
13.1 Company Overview 120
13.2 Business Overview 120
13.2.1 BioScience 120
13.2.2 Medication Delivery 120
13.2.3 Renal 121
13.2.4 Products 121
13.2.5 History 122
13.3 Value Chain Analysis 124
13.3.1 Manufacturing 124
13.3.2 Product Development 124
13.3.3 Sales and Marketing 125
13.4 SWOT Analysis 126
13.4.1 Baxter International Inc. Strengths 126
13.4.2 Baxter International Inc. Weaknesses 127
13.4.3 Baxter International Inc. Opportunities 127
13.4.4 Baxter International Inc. Threats 128
13.5 Financial and Operational Review 129
13.6 Locations And Subsidiaries 131
13.7 Baxter International Inc. Pipeline Products 132
13.7.1 Next-Generation Home Hemodialysis Machine 132
14 Smith & Nephew Plc Company Profile 134
14.1 Company Overview 134
14.2 Business Overview 134
14.2.1 Advanced Wound Management 134
14.2.2 Endoscopy 135
14.2.3 Reconstruction 135
14.2.4 Trauma and Clinical Therapies 136
14.2.5 Products 136
14.2.6 History 137
14.3 Value Chain Analysis 141
14.3.1 Manufacturing 141
14.3.2 Product Development 142
14.3.3 Sales and Marketing 143
14.4 SWOT Analysis 143
14.4.1 Smith & Nephew Plc Strengths 143
14.4.2 Smith & Nephew Plc Weaknesses 144
14.4.3 Smith & Nephew Plc Opportunities 144
14.4.4 Smith & Nephew Plc Threats 145
14.5 Financial and Operational Review 146
14.6 Locations And Subsidiaries 148
14.6.1 Other Locations & Subsidiaries 149
14.7 Smith & Nephew Plc Pipeline Products 150
14.7.1 R3 Modular resurfacing Acetabular system 150
14.7.2 R3 Ceramic-on-ceramic Acetabular System 150
15 Regulation System 151
15.1 Medical Equipment Approval Process 151
15.1.1 Classification 152
15.1.2 Conformity Assessment Process 160
15.1.3 Registration Fee 164
15.1.4 Registration Period 164
15.2 Post Market Surveillance (PMS) 164
16 Pricing and Reimbursement 165
16.1 Pricing and Reimbursement Policies 165
17 Distribution Structure 166
18 Appendix 167
18.1 Global Markets Direct Research Methodology 167
18.2 Coverage 168
18.3 Secondary Research 168
18.4 Primary Research 169
18.5 Models 169
18.6 Forecasts 170
18.7 Expert Panels 170
18.8 Currency Conversion 171
18.9 Contact Us 172
18.10 Disclaimer 172

Executive Summary

1.1 List of Tables
Table 1: Number of Doctors by Specialty in France, 2003-2007 18
Table 2: Number of Hospital Wards by Specialty in France, 2003-2007 19
Table 3: Wound Care Management, France, Overall Revenues ($ mn), 2000-2012 21
Table 4: Wound Care Management, France, Overall Revenues ($ mn), Historic, 2000-2007 22
Table 5: Wound Care Management, France, Overall Revenues ($ mn), Forecast, 2007-2012 23
Table 6: Wound Care Management, France, Category Revenues ($ mn), 2000-2012 24
Table 7: Wound Care Management, France, Category Revenues ($ mn), Historic, 2000-2007 25
Table 8: Wound Care Management, France, Category Revenues ($ mn), Forecast, 2007-2012 26
Table 9: Wound Care Management, France, Category Volume (Units), 2000-2012 27
Table 10: Wound Care Management, France, Category Volume (Units), Historic, 2000-2007 28
Table 11: Wound Care Management, France, Category Volume (Units), Forecast, 2007-2012 29
Table 12: Wound Care Management in France, Overall, Company Share by Revenue ($ mn), 2005-2006 30
Table 13: Wound Closure Devices, France, Overall Revenues ($ mn), Historic, 2000-2007 31
Table 14: Wound Closure Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012 32
Table 15: Wound Closure Devices, France, Revenue by Segment ($ mn), Historic, 2000-2007 33
Table 16: Wound Closure Devices, France, Revenue by Segment ($ mn), Forecast, 2007-2012 34
Table 17: Skin Closure Devices, France, Overall Revenues ($ mn), Historic, 2000-2007 35
Table 18: Skin Closure Devices, France, Overall Revenues ($ mn), Forecast, 2007-2012 36
Table 19: Hemostats, France, Overall Revenues ($ mn), Historic, 2000-2007 37
Table 20: Hemostats, France, Overall Revenues ($ mn), Forecast, 2007-2012 38
Table 21: Tissue Sealants, France, Overall Revenues ($ mn), Historic, 2000-2007 39
Table 22: Tissue Sealants, France, Overall Revenues ($ mn), Forecast, 2007-2012 40
Table 23: Wound Closure Devices, France, Overall Volume (Units), Historic, 2000-2007 41
Table 24: Wound Closure Devices, France, Overall Volume (Units), Forecast, 2007-2012 42
Table 25: Skin Closure Devices, France, Overall Volume (Units), Historic, 2000-2007 43
Table 26: Skin Closure Devices, France, Overall Volume (Units), Forecast, 2007-2012 44
Table 27: Hemostats, France, Overall Volume (Units), Historic, 2000-2007 45
Table 28: Hemostats, France, Overall Volume (Units), Forecast, 2007-2012 46
Table 29: Tissue Sealants, France, Overall Volume (Units), Historic, 2000-2007 47
Table 30: Tissue Sealants, France, Overall Volume (Units), Forecast, 2007-2012 48
Table 31: Hemostats, France, Average Price ($), Historic, 2000-2007 49
Table 32: Hemostats, France, Average Price ($), Forecast, 2007-2012 50
Table 33: Tissue Sealants, France, Average Price ($), Historic, 2000-2007 51
Table 34: Tissue Sealants, France, Average Price ($), Forecast, 2007-2012 52
Table 35: Skin Closure Devices, France, Average Price ($), Historic, 2000-2007 53
Table 36: Skin Closure Devices, France, Average Price ($), Forecast, 2007-2012 54
Table 37: Wound Closure Devices, France, Distribution Share by Revenue ($ mn), 2005-2006 55
Table 38: Wound Closure Devices, France, Company Share by Revenue ($ mn), 2005-2006 56
Table 39: Ostomy, France, Overall Revenues ($ mn), Historic, 2000-2007 57
Table 40: Ostomy, France, Overall Revenues ($ mn), Forecast, 2007-2012 58
Table 41: Ostomy, France, Overall Volume (Units), Historic, 2000-2007 59
Table 42: Ostomy, France, Overall Volume (Units), Forecast, 2007-2012 60
Table 43: Ostomy, France, Average Price ($), Historic, 2000-2007 61
Table 44: Ostomy, France, Average Price ($), Forecast, 2007-2012 62
Table 45: Ostomy, France, Distribution Share by Revenue ($ mn), 2005-2006 63
Table 46: Ostomy, France, Company Share by Revenue Advanced Wound Management, France, Overall Revenues ($ mn), Forecast, 2007-2012 64
Table 47: Advanced Wound Management, France, Overall Revenues ($ mn), Historic, 2000-2007 65
Table 48: Advanced Wound Management, France, Overall Revenues ($ mn), Forecast, 2007-2012 66
Table 49: Advanced Wound Management, France, Overall Volume (Units), Historic, 2000-2007 67
Table 50: Advanced Wound Management, France, Overall Volume (Units), Forecast, 2007-2012 68
Table 51: Advanced Wound Management, France, Average Price ($), Historic, 2000-2007 69
Table 52: Advanced Wound Management, France, Average Price ($), Forecast, 2007-2012 70
Table 53: Advanced Wound Management, France, Distribution Share by Revenue ($ mn), 2005-2006 71
Table 54: Advanced Wound Management, France, Company Share by Revenue ($ mn), 2005-2006 72
Table 55: Traditional Wound Management, France, Overall Revenues ($ mn), Historic, 2000-2007 73
Table 56: Traditional Wound Management, France, Overall Revenues ($ mn), Forecast, 2007-2012 74
\Table 57: Traditional Wound Management, France, Overall Volume (Units), Historic, 2000-2007 75
Table 58: Traditional Wound Management, France, Overall Volume (Units), Forecast, 2007-2012 76
Table 59: Traditional Wound Management, France, Average Price ($), Historic, 2000-2007 77
Table 60: Traditional Wound Management, France, Average Price ($), Forecast, 2007-2012 78
Table 61: Traditional Wound Management, France, Distribution Share by Revenue ($ mn), 2005-2006 79
Table 62: Traditional Wound Management, France, Company Share by Revenue ($ mn), 2005-2006 80
Table 63: Compression Therapy, France, Overall Revenues ($ mn), Historic, 2000-2007 81
Table 64: Compression Therapy, France, Overall Revenues ($ mn), Forecast, 2007-2012 82
Table 65: Compression Therapy, France, Overall Volume (Units), Historic, 2000-2007 83
Table 66: Compression Therapy, France, Overall Volume (Units), Forecast, 2007-2012 84
Table 67: Compression Therapy, France, Average Price ($), Historic, 2000-2007 85
Table 68: Compression Therapy, France, Average Price ($), Forecast, 2007-2012 86
Table 69: Compression Therapy, France, Distribution Share by Revenue ($ mn), 2005-2006 87
Table 70: Compression Therapy, France, Company Share by Revenue ($ mn), 2005-2006 88
Table 71: HARTMANN GROUP, SWOT Analysis, 2006 95
Table 72: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006 99
Table 73: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006 100
Table 74: HARTMANN GROUP, Subsidiaries 101
Table 75: Coloplast A/S, SWOT Analysis, 2007 108
Table 76: Coloplast A/S, Financial Statements, DKK Million, 2003-2007 111
Table 77: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007 112
Table 78: Coloplast A/S, Share Holding Structure 113
Table 79: Coloplast A/S, Other Locations 114
Table 80: Coloplast A/S, Subsidiaries 114
Table 81: Coloplast A/S, Subsidiaries (Contd.) 115
Table 82: Ethicon, Inc., Other Locations 118
Table 83: Ethicon, Inc., Subsidiaries 119
Table 84: Baxter International Inc., SWOT Analysis, 2006 126
Table 85: Baxter International Inc., Financial Statements, USD Million, 2002-2006 129
Table 86: Baxter International Inc., Financial Ratios, USD Million, 2002-2006 130
Table 87: Baxter International Inc., Other Locations 131
Table 88: Baxter International Inc., Subsidiaries 132
Table 89: Smith & Nephew Plc, SWOT Analysis, 2006 143
Table 90: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006 146
Table 91: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006 147
Table 92: Smith & Nephew Plc, Other Locations 149
Table 93: Currency Conversion from USD to Local Currency at 2007 Constant Rate 171

HARTMANN GROUP
Coloplast A/S
Ethicon, Inc.
Baxter International, Inc.
Smith & Nephew Plc

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos